Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Oceania Healthcare (OCA.NZ)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (NZ$) Price Target (NZ$) Rating
2021-09-061.531.65Buy
2021-11-301.311.55Buy
2021-12-101.341.50Buy
2022-05-090.991.55Buy
2022-05-201.041.50Buy
2022-07-040.911.40Buy
2022-10-100.911.30Buy
2022-11-230.791.20Buy
2023-02-070.871.15Buy
2023-05-240.781.05Buy
2023-10-260.690.95Buy
2024-04-150.610.90Buy
2024-06-250.530.85Buy
2024-09-240.770.90Buy
2024-11-220.760.87Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.